Indian Pharmaceutical Manufacturer Acquires Florida Plant
Kegler Brown Hill + Ritter assisted
India-based Strides Pharma, Inc., in the acquisition of an FDA-
approved manufacturing facility in Florida.
Located in Riviera Beach, Florida,
it is the only FDA-approved facility in the U.S. to have integrated
manufacturing-packaging capabilities for soft gel capsules.
Strides acquired
the manufacturing facility under an asset purchase agreement
with Micelle Biopharma, Inc.
for a consideration of $0.5 million and
will invest up to $10 million to build incremental capabilities and add additional dosage formats.
With the addition of
the Florida site, Strides now has eight formulation sites globally catering to the regulated and emerging markets.
Acquisition of U.S. Generics Company by Indian Pharmaceutical Manufacturer
Kegler Brown Hill + Ritter served as
buy-side counsel for India-based Strides Pharma, Inc., in its acquisition of U.S.-based
generics company Vensun Pharmaceuticals, Inc., represented by Goodwin Procter
LLP.
Strides benefits from Vensun’s
strategic focus on niche ANDAs, and its portfolio of 16 commercialized ANDAs,
four of which are partnered with Strides and constitute a significant part of
Vensun’s current revenues of $~17 million.
Vensun’s portfolio also
comprises an additional 13 filed ANDAs, which includes Strides Competitive
Generic Therapy (CGT) designated product with a $400 million market
opportunity. The company also has a development pipeline with two other
partners for ten products.
Acquisition, Refinancing, and Spin-off of Non-core Assets for West Virginia-based Beverage Distributor
We assisted a growing West
Virginia-based beverage distributor through a series of strategic transactions
in 2016 and 2017, including the acquisition of distribution rights, real
estate, and inventory from a distributor in an adjacent territory with
operations in two different markets in West Virginia. This acquisition made our
client one of the largest beverage distributors in the state.
Our
assistance included the negotiation of a new credit facility to finance the acquisition
and to re-finance existing debt, as well as the sale of distribution rights and
inventory of our client’s Ohio and Kentucky franchises. We also provided
guidance on the reorganization of their corporate structure in order to permit
more streamlined post-closing operations and additional future growth, as well
as tax strategy and transition issues.
Sale of Food Safety Consulting and Research Business
Our client, a food safety consulting and research business, sought our advice for its sale to a private-equity fund in 2017, and we provided them with assistance from letter of intent to closing, as well as post-closing personal and estate planning.
This assistance included deal structure and strategy, terms of earn-out and contingent consideration, and advice on applying working capital adjustment to a cash-basis company. We also provided guidance on tax strategy, risk mitigation, and transition issues, and assisted with post-closing estate and tax planning for the client’s family.
